Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I

Detalles Bibliográficos
Autores principales: Chandrasekaran, Balakumar, Saravanan, Muthupandian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240733/
https://www.ncbi.nlm.nih.gov/pubmed/35784709
http://dx.doi.org/10.3389/fphar.2022.916324
_version_ 1784737632837697536
author Chandrasekaran, Balakumar
Saravanan, Muthupandian
author_facet Chandrasekaran, Balakumar
Saravanan, Muthupandian
author_sort Chandrasekaran, Balakumar
collection PubMed
description
format Online
Article
Text
id pubmed-9240733
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92407332022-06-30 Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I Chandrasekaran, Balakumar Saravanan, Muthupandian Front Pharmacol Pharmacology Frontiers Media S.A. 2022-06-15 /pmc/articles/PMC9240733/ /pubmed/35784709 http://dx.doi.org/10.3389/fphar.2022.916324 Text en Copyright © 2022 Chandrasekaran and Saravanan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Chandrasekaran, Balakumar
Saravanan, Muthupandian
Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I
title Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I
title_full Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I
title_fullStr Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I
title_full_unstemmed Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I
title_short Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I
title_sort editorial: pharmacological and biochemical perspectives of kinase inhibitors in cancer and covid-19 therapeutics, volume i
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240733/
https://www.ncbi.nlm.nih.gov/pubmed/35784709
http://dx.doi.org/10.3389/fphar.2022.916324
work_keys_str_mv AT chandrasekaranbalakumar editorialpharmacologicalandbiochemicalperspectivesofkinaseinhibitorsincancerandcovid19therapeuticsvolumei
AT saravananmuthupandian editorialpharmacologicalandbiochemicalperspectivesofkinaseinhibitorsincancerandcovid19therapeuticsvolumei

Ejemplares similares